Grow - Access New Sources of Capital
Sometimes, what your business needs to grow is an injection of fresh capital outside typical debt or equity sources. We are in daily contact with private, institutional, and corporate investors, so we can identify prospective investors, and connect you with the capital you seek.
Here are a just few of our capital raise successes.
Grand River Aseptic Manufacturing
The Charter Group was the lead sponsor of a $5 million Series B fundraising effort for Grand River Aseptic Manufacturing (GRAM). GRAM manufactures small-run, high-value clinical trial drugs that most large pharmaceutical companies cannot produce profitably.
The Charter Group participated in a $2 million Series A capital investment. Playing an active co-lead investor role with Hopen Life Sciences and Hope River Ventures, Charter was instrumental in the completion of the funding to facilitate the commercial launch of the Intervention Insights business.
Alliant Health Care Products
Charter Capital Fund I has made a private investment in Alliant Healthcare Products in Richland, Michigan. Alliant is a veteran owned manufacturer and distributor of medical devices and equipment. The principals of The Charter Group formed Charter Capital I along with other investors to invest in Alliant.
Metabolic Solutions Development Company
Charter Capital Fund II, LLC has made a private investment in Metabolic Solutions Development Company in Kalamazoo, Michigan. MSD is a developer of innovative therapeutics to treat diabetes and related symptoms of metabolic syndrome. The principals of The Charter Group formed Charter Capital Fund II along with other investors to invest in MSD.
Michigan Accelerator Fund I
MAF-1 provides a path to funding and partnerships for the commercialization of new regionally developed opportunities. The Fund invests in early stage Michigan-based companies that fall into one of four technology categories: life sciences technology, advanced manufacturing, homeland security, and alternative energy. The Fund focuses primarily on life science technology.
For more references, and to find out how we can help you access new sources of capital, please contact us.